An innovative, non-pharmaceutical treatment that filters the blood of cancer patients, similar to dialysis, is currently undergoing clinical trials at the Sheba Medical Center in Israel.
Called immunopheresis, this revolutionary technology removes proteins produced by malignant cells that block the body’s natural immune system, enabling the body to better attack and destroy cancerous tumor cells.
Professor Gal Markel, director of the Ella Lemelbaum Institute for Immuno-Oncology at Sheba Medical Center explained that certain cancer cells can protect themselves from the body’s immune system by producing proteins that circulate in the patient’s bloodstream and sabotage the ability of the immune cells to battle disease. He said that the existence of these proteins has been known since the 1990s, but until now, no one knew how to destroy them. Prof. Markel added that the technology, manufactured by Immunicom of San Diego and designated by the FDA as a “breakthrough,” has the ability to “neutralize the cancer by filtering those proteins out of the bloodstream so that the patient’s own immune system can fight effectively, either alone or in tandem with existing immunotherapy drugs.”
Read more at Arutz Sheva.